While the world is transfixed by the high-stakes race to develop a COVID-19 vaccine, an equally crucial competition is heating up to produce targeted antibodies that could provide an instant immunity boost against the virus. Clinical trials of these monoclonal antibodies, which could both prevent and treat the disease, are already underway and could produce signs of efficacy in the next few months, perhaps ahead of vaccine trials.
Science
We must use it effectively. As supplies are limited, priority must be given to vaccinating essential workers and those with the most risky conditions. Some people in all countries must be vaccinated.
ReplyDelete